These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 17149756)
1. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway. Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756 [TBL] [Abstract][Full Text] [Related]
2. Gene therapy approach in prostate cancer cells using an active Wnt signal. Giladi N; Dvory-Sobol H; Sagiv E; Kazanov D; Liberman E; Arber N Biomed Pharmacother; 2007 Oct; 61(9):527-30. PubMed ID: 17904788 [TBL] [Abstract][Full Text] [Related]
3. Targeting the active beta-catenin pathway to treat cancer cells. Dvory-Sobol H; Sagiv E; Kazanov D; Ben-Ze'ev A; Arber N Mol Cancer Ther; 2006 Nov; 5(11):2861-71. PubMed ID: 17121933 [TBL] [Abstract][Full Text] [Related]
4. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Shan BE; Wang MX; Li RQ Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933 [TBL] [Abstract][Full Text] [Related]
5. [Effects of hepatocyte growth factor gene transfection on adriamycin-induced apoptosis of gastric cancer cells in vitro]. Shen JG; Cheong JH; Noh SH; Wang LB Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):338-41. PubMed ID: 17892127 [TBL] [Abstract][Full Text] [Related]
6. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo. Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823 [TBL] [Abstract][Full Text] [Related]
7. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling. Xiang D; Wang D; He Y; Xie J; Zhong Z; Li Z; Xie J Anticancer Drugs; 2006 Aug; 17(7):753-62. PubMed ID: 16926625 [TBL] [Abstract][Full Text] [Related]
8. The suppression of colon cancer cell growth in nude mice by targeting beta-catenin/TCF pathway. Kwong KY; Zou Y; Day CP; Hung MC Oncogene; 2002 Nov; 21(54):8340-6. PubMed ID: 12447697 [TBL] [Abstract][Full Text] [Related]
9. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells. Chen RH; McCormick F Cancer Res; 2001 Jun; 61(11):4445-9. PubMed ID: 11389074 [TBL] [Abstract][Full Text] [Related]
10. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer. Takahashi M; Nakamura Y; Obama K; Furukawa Y Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202 [TBL] [Abstract][Full Text] [Related]
11. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter. He LF; Wang YG; Xiao T; Zhang KJ; Li GC; Gu JF; Chu L; Tang WH; Tan WS; Liu XY Cancer Lett; 2009 Dec; 286(2):196-205. PubMed ID: 19564073 [TBL] [Abstract][Full Text] [Related]
12. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138 [TBL] [Abstract][Full Text] [Related]
13. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector. Kuroda T; Rabkin SD; Martuza RL Cancer Res; 2006 Oct; 66(20):10127-35. PubMed ID: 17047077 [TBL] [Abstract][Full Text] [Related]
14. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex. Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804 [TBL] [Abstract][Full Text] [Related]
15. Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas. Souazé F; Viardot-Foucault V; Roullet N; Toy-Miou-Leong M; Gompel A; Bruyneel E; Comperat E; Faux MC; Mareel M; Rostène W; Fléjou JF; Gespach C; Forgez P Carcinogenesis; 2006 Apr; 27(4):708-16. PubMed ID: 16299383 [TBL] [Abstract][Full Text] [Related]
16. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells. Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019 [TBL] [Abstract][Full Text] [Related]
17. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells. Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613 [TBL] [Abstract][Full Text] [Related]
18. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer. Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120 [TBL] [Abstract][Full Text] [Related]
19. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900 [TBL] [Abstract][Full Text] [Related]
20. Nuclear translocations of beta-catenin and TCF4 in gastric cancers correlate with lymph node metastasis but probably not with CD44 expression. Chen XY; Wang ZC; Li H; Cheng XX; Sun Y; Wang XW; Wu ML; Liu J Hum Pathol; 2005 Dec; 36(12):1294-301. PubMed ID: 16311123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]